Clinical predictors of community-genotype ST72-methicillin-resistant Staphylococcus aureus-SCCmec type IV in patients with community-onset S. aureus infection
Author(s) -
EunJeong Joo,
Doo Ryeon Chung,
Young Eun Ha,
S. Y. Park,
H. A. Kim,
Min-Jung Lim,
Hong Bin Kim,
CheolIn Kang,
Nam Yong Lee,
Kwan Soo Ko,
Kyong Ran Peck,
JaeUk Song
Publication year - 2012
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dks120
Subject(s) - staphylococcus aureus , sccmec , genotype , methicillin resistant staphylococcus aureus , microbiology and biotechnology , staphylococcal infections , panton–valentine leukocidin , micrococcaceae , meticillin , medicine , virology , biology , antibacterial agent , antibiotics , gene , bacteria , genetics
Community-genotype methicillin-resistant Staphylococcus aureus (MRSA) clones have emerged in the community worldwide and recently have been spreading into the hospitals. To identify predictors of sequence type 72-MRSA-SCCmec type IV (ST72-MRSA-IV) in patients with community-onset (CO) S. aureus infection, a case-control study was conducted among CO S. aureus infections, including healthcare-associated infections.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom